SQUAWK/NEWS
Menu
Live News EQUITY M impact

Immunic Inc. 8K Filing

Immunic Inc. files 8K with SEC, disclosing officer changes and financial statements. The filing includes compensatory arrangements of certain officers and regulation FD disclosure.

IMMN

Filed: 2026-05-27 AccNo: 0001193805-26-000696 Size: 372 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits